<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
64730-033-04
</NDCCode>
<PackageDescription>
1 VIAL, SINGLE-DOSE in 1 CARTON (64730-033-04) > 20 mL in 1 VIAL, SINGLE-DOSE
</PackageDescription>
<NDC11Code>
64730-0033-04
</NDC11Code>
<ProductNDC>
64730-033
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Trastuzumab
</NonProprietaryName>
<DosageFormName>
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20200415
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Pierre Fabre Medicament Production
</LabelerName>
<SubstanceName>
TRASTUZUMAB-DTTB
</SubstanceName>
<StrengthNumber>
150
</StrengthNumber>
<StrengthUnit>
mg/20mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2014-02-04
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20211231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>